Viridian Therapeutics Inc.

NASDAQ: VRDN
Share price (3/25/25): $14.80
Market cap (3/25/25): $1.206 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Tripuraneni Radhika

Tripuraneni Radhika

Cain Christopher W.

Cain Christopher W.

Tousignant Jennifer

News Filter

Change in Directors, Officers or Compensation

Material Definitive Agreement, Termination of Material Definitive Agreement, Financial Statements or Exhibits

Highlights Recent Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

Change in Directors, Officers or Compensation

Announces Positive Topline Results From Veligrotug Phase 3 THRIVE-2 Clinical Trial in Patients With Chronic Thyroid Eye Disease

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC